Baader Bank Aktiengesellschaft’s Biogen BIIB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$6.17M Sell
28,568
-2,233
-7% -$427K 0.46% 52
2026
Q1
$5.64M Sell
30,801
-1,690
-5% -$311K 0.44% 53
2025
Q4
$5.71M Sell
32,491
-23,483
-42% -$3.84M 0.39% 55
2025
Q3
$7.83M Buy
+55,974
New +$7.57M 0.51% 41

Other funds holding BIIB

Baader Bank Aktiengesellschaft's BIIB Position: Q2 2026 in Review

Baader Bank Aktiengesellschaft reduced its Biogen (BIIB) stake by 7.2% in Q2 2026, selling an estimated $427K and leaving 28,568 shares worth $6.17M. The position accounts for 0.46% of the portfolio, ranked #52.

Baader Bank Aktiengesellschaft first reported a position in BIIB in Q3 2025 and has held it in 4 quarters since. The position peaked at $7.83M in Q3 2025. 1,042 funds tracked by Wall St. Rank hold BIIB as of Q2 2026.

  • Baader Bank Aktiengesellschaft held 28,568 shares of Biogen worth $6.17M as of Q2 2026.
  • Baader Bank Aktiengesellschaft sold 2,233 Biogen shares in Q2 2026, an estimated $427K.
  • Biogen made up 0.46% of Baader Bank Aktiengesellschaft's portfolio in Q2 2026, its #52 holding.
  • Baader Bank Aktiengesellschaft first reported a position in Biogen in Q3 2025 and has held it in 4 quarters since.
  • Baader Bank Aktiengesellschaft's Biogen position peaked at $7.83M in Q3 2025.
  • 1,042 funds tracked by Wall St. Rank held Biogen as of Q2 2026.

Based on Baader Bank Aktiengesellschaft's 13F filing for Q2 2026, filed 23 Jul 2026.